Mansoura Ophthalmology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Medical Oncology, Oncology Center Mansoura University, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Ann Hematol. 2024 Sep;103(9):3519-3533. doi: 10.1007/s00277-024-05861-2. Epub 2024 Jul 10.
Acute leukemia is a hematological malignancy affecting different organ systems including the eye and orbit through direct infiltration of tissues or secondary to hematological abnormalities. Ophthalmological manifestations in acute leukemia are variable ranging from asymptomatic presentation to serious manifestations that can alter the disease course and treatment. The purpose of this study is to detect the incidence of different ophthalmological manifestations in newly diagnosed acute leukemia patients and to assess the relationship between ocular findings and hematological characteristics and the sequel of these neoplasms. A cross-sectional study with analytical components was conducted on 222 newly diagnosed acute myeloid and acute lymphoblastic leukemia patients who presented at Oncology Center Mansoura University (OCMU) between January 2022 and February 2023. All patients underwent a complete ophthalmic evaluation at Mansoura Ophthalmology Center (MOC). The mean age was 43.45 ± 17.35 years (range, 17-85), and M/F was 137 (61.7%)/85 (38.3%). One-hundred and forty-four (64.9%) had acute myeloid leukemia (AML), and 78 (35.1%) had acute lymphoblastic leukemia (ALL). Ophthalmic manifestations were detected in 96 patients (43.2%). Among them, 4 (1.8%) had poor visual acuity. Retinal hemorrhage (19.8%) and Roth spots (17.1%) were the most common ocular manifestations. Other ophthalmological manifestations observed were orbital involvement (3.2%), ocular motility issues (1.4%), subconjunctival hemorrhage (5.9%), conjunctival chemosis (0.9%),lid swelling (4.1%), lid ecchymosis (3.2%), lagophthalmos (0.5%), lid ptosis (1.8%), retinal venous congestion & tortuosity (4.1%), preretinal hemorrhage (3.2%), vitreous hemorrhage (3.2%), macular affection (2.3%), retinal infiltration (1.8%), exudative retinal detachment (ERD) (1.8%), cotton-wool spots (0.9%), retinal vein occlusion (0.5%), papilledema (2.8%), optic disc infiltration (1.8%), disc pallor (1.8%).AML patients were significantly associated with a higher frequency of ocular affection, retinal hemorrhages, and Roth spots (P 0.028, 0.003, and 0.046, respectively) compared to ALL patients. Retinal hemorrhage was statistically significantly associated with anemia (P 0.021). Ophthalmological manifestations of acute leukemia are heterogeneous; they can be detected at initial presentations or relapse. Some manifestations are asymptomatic, others can affect visual acuity or even alter the disease course. Cooperation between ophthalmologists and haemato-oncologists is crucial for recognizing ocular involvement and disease management.
急性白血病是一种血液系统恶性肿瘤,可通过直接浸润组织或继发于血液学异常而影响包括眼睛和眼眶在内的不同器官系统。急性白血病的眼部表现多种多样,从无症状表现到严重表现不等,可改变疾病进程和治疗方法。本研究旨在检测新诊断的急性白血病患者不同眼部表现的发生率,并评估眼部发现与血液学特征和这些肿瘤的后果之间的关系。2022 年 1 月至 2023 年 2 月期间,在曼苏拉大学肿瘤中心(OCMU)就诊的 222 例新诊断的急性髓系和急性淋巴细胞白血病患者进行了横断面研究,其中包括分析性部分。所有患者均在曼苏拉眼科中心(MOC)接受全面的眼科评估。平均年龄为 43.45±17.35 岁(范围 17-85 岁),男女比例为 137(61.7%)/85(38.3%)。144 例(64.9%)为急性髓系白血病(AML),78 例(35.1%)为急性淋巴细胞白血病(ALL)。96 例(43.2%)患者发现眼部表现。其中,4 例(1.8%)视力不佳。视网膜出血(19.8%)和 Roth 斑(17.1%)是最常见的眼部表现。观察到的其他眼部表现包括眼眶受累(3.2%)、眼球运动问题(1.4%)、球结膜下出血(5.9%)、球结膜水肿(0.9%)、眼睑肿胀(4.1%)、眼睑瘀斑(3.2%)、兔眼(0.5%)、眼睑下垂(1.8%)、视网膜静脉充血和迂曲(4.1%)、视网膜前出血(3.2%)、玻璃体出血(3.2%)、黄斑病变(2.3%)、视网膜浸润(1.8%)、渗出性视网膜脱离(ERD)(1.8%)、棉絮斑(0.9%)、视网膜静脉阻塞(0.5%)、视盘水肿(2.8%)、视盘浸润(1.8%)、视盘苍白(1.8%)。与 ALL 患者相比,AML 患者的眼部受累、视网膜出血和 Roth 斑的发生率明显更高(分别为 P 0.028、0.003 和 0.046)。视网膜出血与贫血呈显著相关(P 0.021)。急性白血病的眼部表现多种多样;它们可以在初始表现或复发时被检测到。一些表现是无症状的,其他表现可能会影响视力,甚至改变疾病进程。眼科医生和血液肿瘤学家之间的合作对于识别眼部受累和疾病管理至关重要。